Safety and efficacy of neoadjuvant combination of hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil, and oxaliplatin with intravenous (iv) cetuximab in patients with unresectable liver metastases from colorectal cancer (CRC): Interim report from OPTILIV—A European multicenter phase II trial.
2011 ◽
Vol 29
(15_suppl)
◽
pp. e14102-e14102
2011 ◽
Vol 29
(15_suppl)
◽
pp. e14134-e14134
2016 ◽
Vol 34
(15_suppl)
◽
pp. e15036-e15036
2016 ◽
Vol 68
◽
pp. 163-172
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 3589-3589
◽